Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

Condition:   ADHD Interventions:   Drug: AMPH ER Tab 5, 10, 15 and 20 mg;   Drug: AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg Sponsors:   Tris Pharma, Inc.;   Premier Research Group plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials